GOTHENBURG, Sweden, Aug. 29, 2019 /PRNewswire/ -- Mölnlycke, a world-leading medical solutions company, successfully launched on 28 August a EUR 500 million senior unsecured bond off its newly established EMTN programme. The bond has a 10-year tenor, Mölnlycke's longest tenor yet, and an annual fixed coupon of 0,875%.
There was strong and widespread investor demand for the bond issue, which was more than 6 times oversubscribed.
The proceeds will be used for a simultaneous buy-back of part of Mölnlycke notes maturing in 2022 and for general corporate purposes. The transaction has enabled Mölnlycke to extend its debt maturity profile and lock in favourable financing conditions to support the Group's continued growth. The company will stay within its financial leverage policy after the bond issue.
Demand came from leading investors in all regions: Germany/Austria 34%, the Nordics 18%, UK/Ireland 16%, France 25%, Switzerland 5%, BeNeLux 3% and Other 4%. Asset managers were the leading investor type with 73%, followed by insurance/pension funds with 17%, while banks contributed with 9%, official institutions and other with 1%.
For more information please contact:
Stefan Fristedt, CFO
+46-31-352-3746
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/molnlycke/r/successful-emtn-programme-establishment-and-10-year-eurobond-issue-for-molnlycke,c2891264
The following files are available for download:
https://mb.cision.com/Main/7824/2891264/1097285.pdf | Press release Mölnlycke Eurobond issue |
